Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for Care
Psychoactives May 12, 2026 Peer reviewed DOI: 10.3390/psychoactives5020014 via OpenAlex
Summary
Lifetime psychedelic use does not lower the odds of missing needed mental health treatment when accounting for psychological distress. However, it appears to weaken the relationship between distress and missed care, particularly in men, who show a smaller increase in missed treatment as distress rises compared to non-users. Among women, only MDMA shows a similar moderating effect. These results indicate that psychedelic use affects engagement with mental health care differently based on gender.
Study at a glance
| Design | observational cohort |
|---|---|
| Population | individuals from the National Survey on Drug Use and Health (2008–2019) |
| Key finding | Psychedelic use does not independently reduce missed needed mental health treatment but moderates the impact of psychological distress on treatment engagement, with variations by gender. |
Abstract
While prior research links psychedelic use to improved psychological outcomes, less is known about whether psychedelic exposure relates to engagement with formal mental health care when treatment is recognized as needed. Using publicly available, de-identified pooled data from the National Survey on Drug Use and Health (2008–2019), this study examines whether lifetime psychedelic use is associated with missed needed mental health treatment and whether psychedelic exposure moderates the relationship between psychological distress and unmet care, with attention to gender differences. Regression analyses indicate that psychedelic use is not independently associated with lower odds of missing needed treatment once psychological distress is accounted for. However, psychedelic exposure is associated with a weaker relationship between distress and missed care: as psychological distress increases, individuals with prior psychedelic use—particularly men—exhibit a smaller increase in missed needed treatment compared to non-users. Gender-stratified analyses show that this buffering pattern is evident for men across multiple substances, whereas among women, only MDMA demonstrates a comparable moderating effect. These findings suggest that psychedelic use does not uniformly increase engagement with mental health care but is associated with gendered differences in how psychological distress translates into disengagement. Situated within the Medical Sociological and Social Epidemiological Psychedelics Paradigm, the results highlight how structural inequality shapes the behavioral translation of psychedelic experiences, producing diminished returns for women despite comparable levels of distress.